Insights / Topic
AI leadership
What leaders should decide, fund, ask, and stop when AI arrives in a regulated organization.
4
essays on this topic
- Regulatory strategy · Making Investment Decisions in China, EU and the United States as Drug Development Regulations Evolve: Technology isn’t just for Medtech, it’s about to Reshape Biotech as We Know it China has emerged as a strategic market, and a leader in some areas of biotech and medtech development, fundamentally altering development and investment landscapes.
- Technology change · From Medicine to Memory: Why we are talking about how AI systems remember things, and why it matters in healthcare Why we are talking about how AI systems remember things, and why it matters in healthcare.
- Regulatory strategy · It’s an AI vs AI World in FDA Review FDA is now using even more sophisticated AI to review regulatory filings, and that impacts clinical trials and commercial strategy.
- Cybersecurity · So Everyone’s Talking About AI in Cybersecurity, What Do I Actually Need to Know? This year it seems like everyone and their boss (often the nontechnical ones too) are talking about cybersecurity and artificial intelligence.
Get in touch
Speaking, teaching, board work, or coaching
I am glad to hear from conference organizers, journalists, students, and leaders who want a thinking partner.